BSIC | Bocconi Students Investment Club
  • Articles
    • Markets
    • Corporate Finance
  • The Team
    • Members
    • Alumni
  • About Us
  • Gallery
  • Join Us
  • Contacts
  • Subscribe
  • Collaborations

swiss

Corporate Finance Old Articles

Novartis-AveXis: an $8.7bn gene repair

Novartis AG (SIX: NOVN) – market cap as of 20/04/2018: CHF204.12bn AveXis Inc (NASDAQ: AVXS) – market cap as of 20/04/2018: $7.62bn Introduction On April 9, Novartis submitted an offer to acquire all the shares of the American gene therapy group AveXis. The Swiss drugmaker offered an 88% premium adding Read more…

By BSIC, 7 years22 April 2018 ago
Markets Old Articles Trade Ideas

Outlook on Investment Banking

The investment banking industry is expected to announce lacklustre returns for 2013, despite an improving global economy, soaring asset prices and abundant liquidity. According to Deutsche Bank, the overall revenue pool is forecasted to be down by 6% (FICC down by 18%, Equity up by 28% mostly driven by equity Read more…

By BSIC, 11 years8 December 2013 ago
Corporate Finance M&A Deals Old Articles

Pharma’s Big Deal of the Year: Shire acquires ViroPharma

Shire PLC Market Cap (as of 15/11/13): £15.7bn ViroPharma Inc. Market Cap (as of 15/11/13): $3.3bn Monday, November 11th brought about the much rumored king-size deal of the year in the pharmaceutical sector: Shire PLC of Ireland acquired ViroPharma Inc., a US-based niche company focused on rare diseases, for a Read more…

By BSIC, 12 years16 November 2013 ago

[instagram-feed]

Follow Us

  • Disclaimer
  • About Us
  • Join Us
  • Contacts
  • Subscribe
  • Privacy Policy
  • Cookie Policy
Hestia | Developed by ThemeIsle